Celanese Corporation Total Assets
Celanese Corporation total assets. Based on the latest financial reports, Celanese Corporation (CE) holds total assets worth $21.41 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Celanese Corporation (CE) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Celanese Corporation (2001–2025)
Total assets of Celanese Corporation from 2001 to 2025. This chart illustrates how Celanese Corporation's total assets have evolved over time, based on quarterly financial data. See Celanese Corporation (CE) share price today for real-time trading data and today's change.
Celanese Corporation - Asset Composition Analysis
Celanese Corporation Total Assets Breakdown (December 2025)
Celanese Corporation total assets breakdown as of December 2025. Celanese Corporation's total assets of $21.41 Billion consist of 26.2% current assets and 73.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.26 Billion | 5.8% |
| Accounts Receivable | $1.47 Billion | 6.8% |
| Inventory | $2.22 Billion | 10.2% |
| Property, Plant & Equipment | $5.43 Billion | 25.1% |
| Intangible Assets | $3.18 Billion | 14.7% |
| Goodwill | $4.17 Billion | 19.2% |
Asset Composition Trend (2001–2025)
This chart illustrates how Celanese Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore CE current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Celanese Corporation's current assets represent 26.2% of total assets in 2025, an increase from 0.0% in 2001.
- Cash Position: Cash and equivalents constituted 5.8% of total assets in 2025, up from 0.0% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 33.0% of total assets, an increase from 0.0% in 2001.
- Asset Diversification: The largest asset category is property, plant & equipment at 25.1% of total assets.
Celanese Corporation Competitors by Total Assets
Key competitors of Celanese Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cathay Biotech Inc
SHG:688065
|
China | CN¥24.61 Billion |
|
Dongyue Group Limited
F:4D3
|
Germany | €23.56 Billion |
|
Shandong Shida Shenghua Chem
SHG:603026
|
China | CN¥12.81 Billion |
|
Yuanli Chemical Group Co Ltd
SHG:603217
|
China | CN¥5.17 Billion |
|
Nanjing Chemical Fibre Co Ltd
SHG:600889
|
China | CN¥1.25 Billion |
|
Yunnan Yunwei Co Ltd Class A
SHG:600725
|
China | CN¥353.34 Million |
|
Jiangxi Chen Guang New Materials Co Ltd
SHG:605399
|
China | CN¥3.28 Billion |
|
Shaanxi Xinghua Chemistry Co Ltd
SHE:002109
|
China | CN¥10.67 Billion |
Celanese Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.23 | 2.05 | 2.40 |
| Quick Ratio | 0.74 | 1.22 | 1.76 |
| Cash Ratio | 0.00 | 0.42 | 0.74 |
| Working Capital | $1.08 Billion | $2.91 Billion | $2.54 Billion |
Celanese Corporation - Advanced Valuation Insights
This section examines the relationship between Celanese Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.16 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | -5.1% |
| Total Assets | $21.70 Billion |
| Market Capitalization | $4.82 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Celanese Corporation's assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Celanese Corporation's assets decreased by 5.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Celanese Corporation (2001–2025)
The table below shows the annual total assets of Celanese Corporation from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $21.70 Billion | -5.08% |
| 2024-12-31 | $22.86 Billion | -14.06% |
| 2023-12-31 | $26.60 Billion | +1.24% |
| 2022-12-31 | $26.27 Billion | +119.39% |
| 2021-12-31 | $11.97 Billion | +9.77% |
| 2020-12-31 | $10.91 Billion | +15.12% |
| 2019-12-31 | $9.48 Billion | +1.75% |
| 2018-12-31 | $9.31 Billion | -2.36% |
| 2017-12-31 | $9.54 Billion | +14.13% |
| 2016-12-31 | $8.36 Billion | -2.67% |
| 2015-12-31 | $8.59 Billion | -2.63% |
| 2014-12-31 | $8.82 Billion | -2.22% |
| 2013-12-31 | $9.02 Billion | -1.53% |
| 2012-12-31 | $9.16 Billion | +7.51% |
| 2011-12-31 | $8.52 Billion | +2.86% |
| 2010-12-31 | $8.28 Billion | -1.53% |
| 2009-12-31 | $8.41 Billion | +17.36% |
| 2008-12-31 | $7.17 Billion | -11.07% |
| 2007-12-31 | $8.06 Billion | +2.06% |
| 2006-12-31 | $7.89 Billion | +6.04% |
| 2005-12-31 | $7.45 Billion | +0.47% |
| 2004-12-31 | $7.41 Billion | +8.75% |
| 2003-12-31 | $6.81 Billion | +6.19% |
| 2002-12-31 | $6.42 Billion | +2.97% |
| 2001-12-31 | $6.23 Billion | -- |
About Celanese Corporation
Celanese Corporation produces and sells engineered polymers worldwide. It operates through Engineered Materials and Acetyl Chain segments. The company offers ethylene acrylic elastomers, ethylene vinyl acetate pharmaceutical grade copolymers, liquid crystal polymers, long-fiber reinforced thermoplastics, nylon and polypropylene compounds and formulations, polyoxymethylene, ultra-high molecular we… Read more